Ikenna Nometa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ikenna Nometa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Omame
Department of Mathematics, Federal University of Technology, Owerri, Nigeria
3 shared publications - Nneka O. Iheonu
Department of Mathematics, Federal University of Technology, Owerri, Nigeria
2 shared publications - Udoka Benedict Odionyenma
Federal University of Technology Owerri
2 shared publications - Bolarinwa Bolaji
Department of Mathematical Sciences, Prince Abubakar Audu University, Anyigba, Nigeria
1 shared publication C. I. Nwakanma
1 shared publicationD. Okuonghae
1 shared publication
Latest Publications
- Open Access
- 30 June 2023
- Published by Mathematical Modelling and Numerical Simulation with Applications in Mathematical Modelling and Numerical Simulation with Applications
- Vol. 3 (2) , 111-140
Analysis of a model to control the co-dynamics of Chlamydia and Gonorrhea using Caputo fractional derivative
This paper investigates a fractional derivative model of Chlamydia-Gonorrhea co-infection using Caputo derivative definition. The positivity boundedness of the model is established using Laplace transform. Additionally, we investigated the existence and uniqueness of the model using methods established by some fixed point theorems. We concluded that the model is Ulam-Hyers-Rassias stable. Furthermore, we obtained plots of the model at different fractional derivative orders, which show the significant role played by the fractional order on various classes of the model as it varies. We observe distinct results for each class in different orders, highlighting the importance of considering the fractional order in modeling Chlamydia-Gonorrhea co-infection. Moreover, the fractional model presented in this paper can be used to study the dynamics of Chlamydia-Gonorrhea co-infection in a more accurate and realistic way compared to traditional integer-order models.
- 30 June 2023
- Published by Mathematical Modelling and Numerical Simulation with Applications in Mathematical Modelling and Numerical Simulation with Applications
- Vol. 3 (2) , 111-140
Open AccessAnalysis of a model to control the co-dynamics of Chlamydia and Gonorrhea using Caputo fractional derivative
This paper investigates a fractional derivative model of Chlamydia-Gonorrhea co-infection using Caputo derivative definition. The positivity boundedness of the model is established using Laplace transform. Additionally, we investigated the existence and uniqueness of the model using methods established by some fixed point theorems. We concluded that the model is Ulam-Hyers-Rassias stable. Furthermore, we obtained plots of the model at different fractional derivative orders, which show the significant role played by the fractional order on various classes of the model as it varies. We observe distinct results for each class in different orders, highlighting the importance of considering the fractional order in modeling Chlamydia-Gonorrhea co-infection. Moreover, the fractional model presented in this paper can be used to study the dynamics of Chlamydia-Gonorrhea co-infection in a more accurate and realistic way compared to traditional integer-order models.
- 1 April 2021
- Published by Springer Nature in International Journal of Dynamics and Control
- Vol. 10 (1) , 332-348
Optimal control of Chlamydia model with vaccination
- 1 April 2021
- Published by Springer Nature in International Journal of Dynamics and Control
- Vol. 10 (1) , 332-348
Optimal control of Chlamydia model with vaccination
- Open Access
Optimal Control of Chlamydia Model with Vaccination
This paper presents an SVEIRT epidemiological model in the human population with Chlamydia trachomatis. The model incorporated the vaccination class and investigated the role played by some control strategies in the dynamics of the disease (Chlamydia tracomatis). The reproduction number which helps in determining the rate of spread of the disease, was calculated using the method proosed by van den Driessche and Watmough. The local and global stability of the equlibrium points where established, where it was observed that the model is locally asymptotically stable if the reproduction number is less than unity, and globally stable if a certain threshold value is greater than unity or the re-nfection rate is zero. The effect of the re-infection rate on the global stability suggests the exhibition of the phenomenon of backward bifurcation of the model. The backward bifurcation of the system was later studied, and it shows that backward bifurcation will occur if the value of the bifurcation parameter ‘a’ is positive. The optimal control of the model shows the effect of different strategies in the transmission dynamicsof the disease and the cost effectivenes of each control pair. It was observed that the treatment and control effort gives the most cost effective combinations and at the same time the highest rate of disease avertion when compared to other stratagies. Sensitivity analysis of the parameters as shown in model, shows parameters that have high impact on the chosen classes.
Open AccessOptimal Control of Chlamydia Model with Vaccination
This paper presents an SVEIRT epidemiological model in the human population with Chlamydia trachomatis. The model incorporated the vaccination class and investigated the role played by some control strategies in the dynamics of the disease (Chlamydia tracomatis). The reproduction number which helps in determining the rate of spread of the disease, was calculated using the method proosed by van den Driessche and Watmough. The local and global stability of the equlibrium points where established, where it was observed that the model is locally asymptotically stable if the reproduction number is less than unity, and globally stable if a certain threshold value is greater than unity or the re-nfection rate is zero. The effect of the re-infection rate on the global stability suggests the exhibition of the phenomenon of backward bifurcation of the model. The backward bifurcation of the system was later studied, and it shows that backward bifurcation will occur if the value of the bifurcation parameter ‘a’ is positive. The optimal control of the model shows the effect of different strategies in the transmission dynamicsof the disease and the cost effectivenes of each control pair. It was observed that the treatment and control effort gives the most cost effective combinations and at the same time the highest rate of disease avertion when compared to other stratagies. Sensitivity analysis of the parameters as shown in model, shows parameters that have high impact on the chosen classes.
- Open Access
- 4 August 2020
- Published by Cold Spring Harbor Laboratory in medRxiv
Analysis of COVID-19 and comorbidity co-infection Model with Optimal Control
The new coronavirus disease 2019 (COVID-19) infection is a double challenge for people infected with comorbidities such as cardiovascular and cerebrovascular diseases and diabetes. Comorbidities have been reported to be risk factors for the complications of COVID-19. In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 infection in order to assess the impacts of prior comorbidity on COVID-19 complications and COVID-19 re-infection. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the parameter accounting for increased susceptibility to COVID-19 infection by comorbid susceptibles as well as the rate of re-infection by those who have recovered from a previous COVID-19 infection. Sensivity analysis of the model when the population of individuals co-infected with COVID-19 and comorbidity is used as response function revealed that the top ranked parameters that drive the dynamics of the co-infection model are the effective contact rate for COVID-19 transmission, βCV, the parameter accounting for increased sucseptibility to COVID-19 by comorbid susceptibles, χCM, the comorbidity development rate, θCM, the detection rate for singly infected and co-infected individuals, η1 and η2, as well as the recovery rate from COVID-19 for co-infected individuals, φI2. Simulations of the model reveal that the cumulative confirmed cases (without comorbidity) may get up to 180,000 after 200 days, if the hyper susceptibility rate of comorbid susceptibles is as high as 1.2 per day. Also, the cumulative confirmed cases (including those co-infected with comorbidity) may be as high as 1000,000 cases by the end of November, 2020 if the re-infection rates for COVID-19 is 0.1 per day. It may be worse than this if the re-infection rates increase higher. Moreover, if policies are strictly put in place to step down the probability of COVID-19 infection by comorbid susceptibles to as low as 0.4 per day and step up the detection rate for singly infected individuals to 0.7 per day, then the reproduction number can be brought very low below one, and COVID-19 infection eliminated from the population. In addition, optimal control and cost-effectiveness analysis of the model reveal that the the strategy that prevents COVID-19 infection by comorbid susceptibles has the least ICER and is the most cost-effective of all the control strategies for the prevention of COVID-19.
- 4 August 2020
- Published by Cold Spring Harbor Laboratory in medRxiv
Open AccessAnalysis of COVID-19 and comorbidity co-infection Model with Optimal Control
The new coronavirus disease 2019 (COVID-19) infection is a double challenge for people infected with comorbidities such as cardiovascular and cerebrovascular diseases and diabetes. Comorbidities have been reported to be risk factors for the complications of COVID-19. In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 infection in order to assess the impacts of prior comorbidity on COVID-19 complications and COVID-19 re-infection. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the parameter accounting for increased susceptibility to COVID-19 infection by comorbid susceptibles as well as the rate of re-infection by those who have recovered from a previous COVID-19 infection. Sensivity analysis of the model when the population of individuals co-infected with COVID-19 and comorbidity is used as response function revealed that the top ranked parameters that drive the dynamics of the co-infection model are the effective contact rate for COVID-19 transmission, βCV, the parameter accounting for increased sucseptibility to COVID-19 by comorbid susceptibles, χCM, the comorbidity development rate, θCM, the detection rate for singly infected and co-infected individuals, η1 and η2, as well as the recovery rate from COVID-19 for co-infected individuals, φI2. Simulations of the model reveal that the cumulative confirmed cases (without comorbidity) may get up to 180,000 after 200 days, if the hyper susceptibility rate of comorbid susceptibles is as high as 1.2 per day. Also, the cumulative confirmed cases (including those co-infected with comorbidity) may be as high as 1000,000 cases by the end of November, 2020 if the re-infection rates for COVID-19 is 0.1 per day. It may be worse than this if the re-infection rates increase higher. Moreover, if policies are strictly put in place to step down the probability of COVID-19 infection by comorbid susceptibles to as low as 0.4 per day and step up the detection rate for singly infected individuals to 0.7 per day, then the reproduction number can be brought very low below one, and COVID-19 infection eliminated from the population. In addition, optimal control and cost-effectiveness analysis of the model reveal that the the strategy that prevents COVID-19 infection by comorbid susceptibles has the least ICER and is the most cost-effective of all the control strategies for the prevention of COVID-19.